Announced
Synopsis
Sonic Healthcare, an Australian medical laboratory company, acquired Aurora Diagnostics, pathology services and cancer diagnostics company, for $540m. The acquisition of Aurora is expected to be about 3% EPS accretive post-placement on a pro-forma FY2019 basis before expected revenue and cost synergies, Sonic said in a statement. The acquisition will help Sonic substantially grow its operations in the United States.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.